Stockreport

Cingulate Announces Exercise of Warrants for $1.86 Million Gross Proceeds

Cingulate Inc.  (CING) 
PDF KANSAS CITY, Kan., June 28, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (the “Company”) (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Tim [Read more]